Group 6 Copy 80
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    An initial exploration of in-situ underwater genetic sequencing

    Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...

    Which of Cameroon's peoples have members of haplogroup A00?

    We're now aiming for a higher $9000 Stretch Goal in Round Two of our fundraising, for our groundbreaking...

    The GMO Corn Experiment

    We are testing the hypothesis that wild animals such as squirrels and deer prefer non-GMO corn, and avoid...

    Backer Badge Funded

    A biology project funded by 47 people